Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study

BACKGROUND: Approximately 25% of kidney transplant recipients develop de novo anti-HLA donor-specific antibodies (dnDSA) leading to acute antibody-mediated rejection (ABMR) in 30% of patients. Preemptive therapeutic strategies are not available. METHODS: We conducted a prospective observational stud...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Matignon, Marie, Pilon, Caroline, Commereuc, Morgane, Grondin, Cynthia, Leibler, Claire, Kofman, Tomek, Audard, Vincent, Cohen, José, Canoui-Poitrine, Florence, Grimbert, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487035/
https://ncbi.nlm.nih.gov/pubmed/28654684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0178572
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados